American Healthcare REIT Inc is a healthcare-focused real estate investment trust... Show more
The Stochastic Oscillator for AHR moved into oversold territory on October 03, 2025. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AHR advanced for three days, in of 124 cases, the price rose further within the following month. The odds of a continued upward trend are .
AHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 136 cases where AHR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for AHR moved out of overbought territory on September 11, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 15 similar instances where the indicator moved out of overbought territory. In of the 15 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on October 02, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AHR as a result. In of 27 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for AHR turned negative on September 02, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 15 similar instances when the indicator turned negative. In of the 15 cases the stock turned lower in the days that followed. This puts the odds of success at .
AHR moved below its 50-day moving average on October 03, 2025 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AHR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.848) is normal, around the industry mean (2.041). AHR has a moderately low P/E Ratio (0.000) as compared to the industry average of (44.648). AHR's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (3.232). AHR has a moderately low Dividend Yield (0.024) as compared to the industry average of (0.063). P/S Ratio (2.884) is also within normal values, averaging (6.853).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.
Industry ManagedHealthCare
A.I.dvisor indicates that over the last year, AHR has been loosely correlated with CTRE. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if AHR jumps, then CTRE could also see price increases.
Ticker / NAME | Correlation To AHR | 1D Price Change % | ||
---|---|---|---|---|
AHR | 100% | -1.02% | ||
CTRE - AHR | 62% Loosely correlated | +1.20% | ||
WELL - AHR | 62% Loosely correlated | -0.26% | ||
VTR - AHR | 60% Loosely correlated | +0.24% | ||
OHI - AHR | 57% Loosely correlated | -1.13% | ||
NHI - AHR | 57% Loosely correlated | -0.15% | ||
More |
Ticker / NAME | Correlation To AHR | 1D Price Change % |
---|---|---|
AHR | 100% | -1.02% |
Managed Health Care industry (28 stocks) | 71% Closely correlated | -0.43% |
Health Services industry (434 stocks) | 29% Poorly correlated | +0.57% |